"The data paint a bleak picture.

Steven 🌞 Snedkers billede
Af Steven 🌞 Snedker den 15. august 2014 - 5:02 [1]

"The data paint a bleak picture. The economists find that pharmaceutical companies conduct 30 times more clinical trials for recurrent cancer drugs than for preventive drugs (the effect persists even after adjusting for market size). The authors also show that firms divert their R&D expenditures away from more curable, localised cancers and focus on incurable metastatic and recurrent cancers instead. The patent system encourages pharmaceuticals to pump out drugs aimed at those who have almost no chance of surviving the cancer anyway. This patent distortion costs the U.S. economy around $89 billion a year in lost lives."

http://www.economist.com/blogs/freeexchange/2014/08/innovation âŸČ

Kommentarer


          Morten Juhl-Johansen ZƑlde-FejĂ©r
        s billede

Jeg kan anbefale denne ĂŠldre artikel af Tony Mobily:

http://www.freesoftwaremagazine.com/articles/editorial_09 âŸČ

- den er stof til eftertanke.

TilfĂžj kommentar

Ja, dette er et dumt spÞrgsmÄl med et nemt svar, men det er der kun fordi spam-robotter er for dumme til at besvare den slags, mens mennesker ikke er.
👍

Log ind eller registrer dig for at lægge langtidsholdbare, konstruktive kommentarer.
Registrerede brugere får bedre editor og flere likes.